Yazar-Klosinski B

Freedom Biosciences, Corte Madera, CA, USA.

10 papers · 1 preprint · ORCID

Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA.

Semple MG, Mennenga SE, Smith R +6

Brain-epigenome wide association study (BEWAS) on the effects of two emerging psychedelics: ketamine & MDMA

Semple MG, Mennenga SE, Smith R +6

MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis.

Huestis MA, Smith WB, Leonowens C +5

Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.

Jerome L, Feduccia AA, Wang JB +5

Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.

Mithoefer MC, Feduccia AA, Jerome L +7

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Mitchell JM, Bogenschutz M, Lilienstein A +35

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.

Feduccia AA, Jerome L, Yazar-Klosinski B +3

Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA.

Nair JB, Hakes L, Yazar-Klosinski B +1

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.

Wolfson PE, Andries J, Feduccia AA +10